Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal

Molecular Brain Research

Volumn 112, Issue 1-2, 2003, Pages 113-125

  Ammon, Susanne ^a   Mayer, Peter ^a   Riechert, Uta ^a   Tischmeyer, Helga ^a   Höllt, Volker ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

DNA microarray; Gene expression; Morphine; Rat brain

Indexed keywords

HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 105; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; ION CHANNEL; MORPHINE; NALOXONE; NEUROTRANSMITTER; OPIATE ANTAGONIST; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DNA MICROARRAY; FRONTAL CORTEX; GENE EXPRESSION; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPIATE ADDICTION; PLASTICITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT;

ANIMALIA; STAPHYLOCOCCUS PHAGE 3A;

EID: 0037430852     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(03)00057-3     Document Type: Article

References (45)

1. Abarca A., Albrecht U., Spanagel R. Cocaine sensitization and reward are under the influence of circadian genes and rhythm. Proc. Natl. Acad. Sci. 99:2002;9026-9030.
2. Abs R., Verhelst J., Maeyert J., van Buyten J.P., Opsomer F., Adriaensen H., Verlooy J., van Havenbergh T., Smet M., van Acker K. Endocrine consequences of long-term intrathecal administration of opioids. J. Clin. Endocrinol. Metab. 85:2000;2215-2222.
3. Andretic R., Chaney S., Hirsh J J. Requirement of circadian genes for cocaine sensitization in Drosophila. Science. 285:1999;1066-1068.
4. Bhat R.V., Worley P.F., Cole A.J., Baraban J.M. Activation of the zinc finger encoding gene krox-20 in adult rat brain: comparison with zif268. Brain Res. Mol. Brain Res. 13:1992;263-266.
5. Berke J.D., Paletzki R.F., Aronson G.J., Hyman S.E., Gerfen C.R. A complex program of striatal gene expression induced by dopaminergic stimulation. J. Neurosci. 18:1998;5301-5310.
6. Bottai D., Guzowski J.F., Schwarz M.K., Kang S.H., Xiao B., Lanahan A., Worley P.F., Seeburg P.H. Synaptic activity-induced conversion of intronic to exonic sequence in Homer 1 immediate early gene expression. J. Neurosci. 22:2002;167-175.
7. Budde L.M., Ghosh S. Cloning and characterization of the gene encoding mouse IκBβ Gene. 247:2000;279-286.
8. Capasso A. Involvement of nuclear factor-kB in the expression of opiate withdrawal. Prog. Neuropsychopharmacol. Biol. Psychiatry. 25:2001;1259-1268.
9. Castella P., Wagner J.A., Caudy M. Regulation of hippocampal neuronal differentiation by the basic helix-loop-helix transcription factors HES-1 and MASH-1. J. Neurosci. Res. 56:1999;229-240.
10. Couceyro P., Douglass J. Precipitated morphine withdrawal stimulates multiple activator protein-1 signaling pathways in rat brain. Mol. Pharmacol. 47:1995;29-39.
11. Erdtmann-Vourliotis M., Mayer P., Riechert U., Händel M., Kriebitzsch J., Höllt V. Rational design of oligonucleotide probes to avoid optimization steps in in situ hybridization. Brain Res. Brain Res. Protoc. 4:1999;82-91.
12. Erdtmann-Vourliotis M., Mayer P., Riechert U., Grecksch G., Höllt V. Identification of brain regions that are markedly activated by morphine in tolerant but not in naive rats. Brain Res. Mol. Brain Res. 61:1998;51-61.
13. Fitzgerald L.R., Vaidya V.A., Terwilliger R.Z., Duman R.S. Electroconvulsive seizure increases the expression of CREM (cyclic AMP response element modulator) and ICER (inducible cyclic AMP early repressor) in rat brain. J. Neurochem. 66:1996;429-432.
14. Foulkes N.S., Laoide B.M., Schlotter F., Sassone-Corsi P. Transcriptional antagonist cAMP-responsive element modulator (CREM) downregulates c-fos AMP-induced expression. Proc. Natl. Acad. Sci. 88:1991;5448-5452.
15. Gutstein H.B., Thome J.L., Fine J.L., Watson S.J., Akil H. Pattern of c-fos mRNA induction in rat brain by acute morphine. Can. J. Physiol. Pharmacol. 76:1998;294-303.
16. Herdegen T., Leah J.D. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Brain Res. Rev. 28:1998;370-490.
17. Hu S.B., Nowak F.V. Regional distinction in age-related changes of preoptic regulatory factor-1 and preoptic regulatory factor-2 mRNA expression in the rat brain. Mol. Cell Neurosci. 5:1994;376-381.
18. Hyman S.E., Malenka R.C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nature Rev. 2:2001;695-703.
19. Kelz M.B., Chen J., Carlezon W.A. Jr., Whisler K., Gilden L., Beckmann A.M., Steffen C., Zhang Y.J., Marotti L., Self D.W., Tkatch T., Baranauskas G., Surmeier D.J., Neve R.L., Duman R.S., Picciotto M.R., Nestler E.J. Expression of the transcription factor ΔFosB in the brain controls sensitivity to cocaine. Nature. 401:1999;272-276.
20. Li S., Pelletier G. Opioid regulation of gonadotropin-releasing hormone gene expression in the male rat brain as studied by in situ hybridization. NeuroReport. 4:1999;331-333.
21. Li J.Y., Lescure P.A., Misek D.E., Lai Y.M., Biao-Xin C., Kuick R., Thompson R.C., Demo R.M., Kurnit D.M., Micahelidis G., Hanaah S.M., Gantz I. Food deprivation-induced expression of minoxidil sulfotransferase in the hypothalamus uncovered by microarray analysis. J. Biol. Chem. 277:2002;9069-9076.
22. Lipshutz R.J., Fodor S.P.A., Gingeras T.R., Lockhart D.J. High density synthetic oligonucleotide arrays. Nat. Genet. 21:1999;20-24.
23. Loguinov A.V., Anderson L.M., Crosby G.J., Yukhananov R.Y. Gene expression following acute morphine administration. Physiol. Genom. 6:2001;169-181.
24. Lyford G.L., Yamagata K., Kaufmann W.E., Barnes C.A., Sanders L.K., Copeland N.G., Gilbert D.J., Jenkins N.A., Lanahan A.A., Worley P.F. Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron. 4:1995;433-445.
25. Marchant E.G., Mistlberger R.E. Morphine phase-shifts circadian rhythms in mice: role of behavioural activation. Neuroreport. 7:1995;209-212.
26. Maruyama K., Tsukada T., Ohkura N., Bandoh S., Hosono T., Yamaguchi K. The NGFI-B subfamily of the nuclear receptor superfamily. Int. J. Oncol. 12:1998;1237-1243.
27. Mayer P., Ammon S., Braun H., Tischmeyer H., Riechert U., Kahl E., Höllt V. Gene expression profile after intense second messenger activation in cortical primary neurons. J. Neurochem. 82:2002;1077-1086.
28. Mucha R.F., Kalant H., Kim C. Tolerance to hyperthermia produced by morphine in rat. Psychopharmacology. 92:1987;452-458.
29. Nestler E.J., Aghajanian G.K. Molecular and cellular basis of addiction. Science. 278:1997;58-63.
30. Nestler E.J., Barrot M., Self D.W. ΔFosB: A sustained molecular switch for addiction. Proc. Natl. Acad. Sci. 98:2001;11042-11046.
31. Nikaido T., Akiyama M., Moriya T., Shibata S. Sensitized increase of period gene expression in the mouse caudate/putamen caused by repeated injection of methamphetamine. Mol. Pharmacol. 59:2001;894-900.
32. Noble F., Szucs M., Kieffer B., Roques B.P. Overexpression of dynamin is induced by chronic stimulation of mu - but not δ-opioid receptors: relationships with μ-related morphine dependence. Mol. Pharmacol. 58:2000;159-166.
33. Nowak F.V., Torres G.E., Hu S.H. Differential gene expression response to gonadal hormones by preoptic regulatory factors-1 and -2 in the female rat brain. Neuroendocrinology. 69:1999;191-201.
34. Osada S., Takano K., Nishihara T., Suzuki T., Muramatsu M., Imagawa M. CCAAT/enhancer-binding proteins α and β interact with the silencer element in the promoter of glutathione S-transferase P gene during hepatocarcinogenesis. J. Biol. Chem. 270:1995;31288-31293.
35. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 3rd Edition: 1997;Academic Press, San Diego, CA.
36. Popov N., Pohle W., Lössner B., Schulzeck S., Schmidt S., Ott T., Matthies H. Regional distribution of RNA and protein radioactivity in the rat brain after intraventricular application of labeled precursors. Acta Biol. Med. Germ. 31:1973;51-62.
37. Przewlocka B., Lason W., Przewlocki R. The effect of chronic morphine and cocaine administration on the Gs and Go protein messenger RNA levels in the rat hippocampus. Neuroscience. 63:1994;1111-1116.
38. Rasmussen D.D., Liu J.H., Li M.T., Wolf P.L., Yen S.S.C. Endogenous opioid regulation of gonadotropin-releasing hormone release from the fetal hypothalamus in vitro. J. Clin. Endocrinol. Metab. 57:1983;881-884.
39. Sharp F.R., Massa S.M., Swanson R.A. Heat-shock protein protection. Trends Neurolog. Sci. 22:1999;97-99.
40. Shearman L.P., Zylka M.J., Weaver D.R., Kolakowski Jr L.F., Reppert S.M. Two period homologs: circadian expression and photic regulation in the suprachiasmatic nuclei. Neuron. 19:1997;1261-1269.
41. Steward O., Worley P.F. A cellular mechanism for targeting newly synthesized mRNAs to synaptic sites on dendrites. Proc. Natl. Acad. Sci. 98:2001;7062-7068.
42. Takebayashi K., Sasai Y., Sakai Y., Watanabe T., Nakanishi S., Kageyama R. Structure, chromosomal locus, and promoter analysis of the gene encoding the mouse helix-loop-helix factor HES-1. Negative autoregulation through the multiple N box elements. J. Biol. Chem. 269:1994;5150-5156.
43. Tirumalai P.S., Howells R.D. Regulation of calbindin-D28K gene expression in response to acute and chronic morphine administration. Brain Res. Mol. Brain Res. 23:1994;144-150.
44. Uylings H.B.M., van Eden C.G. Qualitative and quantitative comparison of the prefrontal cortex in rat and in primates, including humans. Prog. Brain. Res. 85:1990;31-62.
45. Xiao B., Tu J.C., Worley P.F. Homer, a link between neuronal activity and glutamate receptor function. Curr. Opin. Neurobiol. 10:2000;370-374.